Litcius/Paper detail

Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats

Henry T. Hsueh, Renee Ti Chou, Usha Rai, Patricia Kolodziejski, Wathsala Liyanage, Jahnavi Pejavar, Ann Mozzer, Charlotte Davison, Matthew B. Appell, Yoo Chun Kim, Kirby T. Leo, HyeYoung Kwon, Maanasa Sista, Nicole M. Anders, Avelina Hemingway, Sri Vishnu Kiran Rompicharla, Ian Pitha, Donald J. Zack, Justin Hanes, Michael P. Cummings, Laura M. Ensign

2023Journal of Controlled Release10 citationsDOIOpen Access PDF

Topics & Concepts

DosingMedicinePharmacologyEye dropNeuroprotectionGanglion cell layerDrug deliveryDrugRetinal ganglion cellOphthalmologyRetinalChemistryOrganic chemistryRetinal Development and DisordersCorneal Surgery and Treatments
Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats | Litcius